The pharmacological management of NAFLD in children and adolescents.
Publication Date
2017-11Journal Title
Expert Rev Clin Pharmacol
ISSN
1751-2433
Publisher
Informa UK Limited
Volume
10
Issue
11
Pages
1225-1237
Language
eng
Type
Article
This Version
AM
Physical Medium
Print-Electronic
Metadata
Show full item recordCitation
Liyanagedera, S., Williams, R. P., Veraldi, S., Nobili, V., & Mann, J. (2017). The pharmacological management of NAFLD in children and adolescents.. Expert Rev Clin Pharmacol, 10 (11), 1225-1237. https://doi.org/10.1080/17512433.2017.1365599
Abstract
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) represents a spectrum, including 'simple' steatosis, non-alcoholic steatohepatitis (NASH), and fibrosis. Increasing prevalence of NAFLD has followed the international rise in obesity and lifestyle modification is the mainstay therapy for children. To date, pharmacological trials have had varying efficacy but a large number of new agents are in early phase trials for adults. Areas covered: This review explores the effect of current and potential future paediatric NAFLD treatments in terms of histological and biochemical endpoints. The potential for the extension of adult treatments to children is discussed, as well as what limits the use of certain agents in children. Expert commentary: No drugs have yet to be licenced for NAFLD. Trial heterogeneity makes comparison of drugs between studies challenging. FXR agonists are yet to be trialled in children but may represent a safe and potentially efficacious therapy. Future treatments would likely encompass a multimodal approach that may include bariatric surgery.
Keywords
Animals, Humans, Obesity, Receptors, Cytoplasmic and Nuclear, Prevalence, Life Style, Age Factors, Drug Design, Adolescent, Adult, Child, Non-alcoholic Fatty Liver Disease
Identifiers
External DOI: https://doi.org/10.1080/17512433.2017.1365599
This record's URL: https://www.repository.cam.ac.uk/handle/1810/287322
Rights
Licence:
http://www.rioxx.net/licenses/all-rights-reserved
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.